Odyssey Therapeutics Inc (ODTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 03-2025 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 35,719 | 41,687 | 0 |
| Marketable Securities | 140,030 | 139,671 | 0 |
| TOTAL | $185,101 | $190,656 | $0 |
| Non-Current Assets | |||
| PPE Net | 6,556 | 7,209 | N/A |
| Investments And Advances | 0 | 35,198 | 0 |
| Intangibles | 14,232 | 14,589 | 0 |
| Other Non-Current Assets | 23,181 | 22,136 | 0 |
| TOTAL | $43,969 | $79,132 | $N/A |
| Total Assets | $229,070 | $269,788 | $0 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 8,219 | 7,872 | 0 |
| Accrued Expenses | 8,618 | 13,392 | 0 |
| TOTAL | $22,211 | $26,475 | $0 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 26,995 | 28,033 | 0 |
| TOTAL | $26,995 | $28,033 | $N/A |
| Total Liabilities | $49,206 | $54,508 | $0 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 48,031 | N/A | N/A |
| Retained earnings | -606,401 | -568,139 | 0 |
| Other shareholders' equity | 703,411 | 703,803 | 0 |
| TOTAL | $179,864 | $215,280 | $0 |
| Total Liabilities And Equity | $229,070 | $269,788 | $0 |